TBThomas Brabletz

Thomas Brabletz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas Brabletz has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2007
      • Vol. 10  (1) , 20-2

    Frontiers in Cancer Prevention Research - Fifth Annual AACR Conference.

    by Thomas Brabletz

  • Top Cited Papers

    Migrating cancer stem cells — an integrated concept of malignant tumour progression

    by Thomas Brabletz, Andreas Jung, Simone Spaderna, Falk Hlubek, Thomas Kirchner

    The dissemination of tumour cells is the prerequisite of metastases and is correlated with a loss of epithelial differentiation and the acquisition of a migratory phenotype, a hallmark of malignant tumour progression. A stepwise, irreversible accumulation of genetic alterations is considered to be the responsible driving force. But strikingly, metastases of most carcinomas recapitulate the organization of their primary tumours. Although current models explain distinct and important aspects of carcinogenesis, each alone can not explain the sum of the cellular changes apparent in human cancer progression. We suggest an extended, integrated model that is consistent with all aspects of human tumour progression - the 'migrating cancer stem (MCS)-cell' concept.


  • Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-Catenin

    by Thomas Brabletz, Falk Hlubek, Simone Spaderna, Otto Schmalhofer, Elke Hiendlmeyer, Andreas Jung, Thomas Kirchner

    Invasion by colorectal carcinomas is characterized by an epithelial-mesenchymal transition (EMT)-like dedifferentiation of the tumor cells. However, a redifferentiation towards an epithelial phenotype, resembling a mesenchymal-epithelial transition, is detectable in metastases. This indicates that malignant progression is based on dynamic processes, which cannot be explained solely by irreversible genetic alterations, but must be additionally regulated by the tumor environment. The main oncoprotein in colorectal cancer is the Wnt pathway effector β-catenin, which is overexpressed due to mutations in the APC tumor suppressor in most cases. EMT of the tumor cells is associated with a nuclear accumulation of the transcriptional activator β-catenin, which is reversed in metastases. Nuclear β-catenin is involved in two fundamental processes in embryonic development: EMT and stem cell formation. Accumulating data demonstrate that aberrant nuclear expression of β-catenin can also confer these two abilities to tumor cells, thereby driving malignant tumor progression.


  • Down-Regulation of the Homeodomain Factor Cdx2 in Colorectal Cancer by Collagen Type I

    by Thomas Brabletz, Simone Spaderna, Jochen Kolb, Falk Hlubek, Gerhard Faller, Christiane J. Bruns, Andreas Jung, Jens Nentwich, Isabelle Duluc, Claire Domon-Dell, et al.

    The homeobox transcription factor Cdx2 specifies intestinal development and homeostasis and is considered a tumor suppressor in colorectal carcinogenesis. However, Cdx2 mutations are rarely found. Invasion of colorectal cancer is characterized by a transient loss of differentiation and nuclear accumulation of the oncoprotein β-catenin in budding tumor cells. Strikingly, this is reversed in growing metastases, indicating that tumor progression is a dynamic process that is not only driven by genetic alterations but also regulated by the tumor environment. Here we describe a transient loss of Cdx2 in budding tumor cells at the tumor host interface, and reexpression of Cdx2 in metastases. Cell culture experiments show that collagen type I, through β1 integrin signaling, triggers a transient transcriptional down-regulation of Cdx2 and its intestine-specific target gene sucrase isomaltase, associated with a loss of differentiation. These data indicate an active role for the tumor environment in malignant tumor progression.


  • In Vivo Functions of Catenins

    by T. Brabletz

    The adhesion of cells to neighbor cells determines cellular and tissue morphogenesis and regulates major cellular processes including motility, growth, survival, and differentiation. Regions of cell-cell adhesion are adherens junctions, desmosomes, and tight junctions. Cadherins are transmembrane molecules whose extracellular domains transmit the direct interaction of two cells. The intracellular cadherin domains bind directly or indirectly to the submembranous catenins, which are linked to the cytoskeleton. Four types of catenins, α-catenin, β-catenin, γ-catenin, and p120 catenin are known. Three of them, β-, γ-, and p120 catenin, are structurally related and possess similar protein interaction domains, the so-called armadillo repeats. These catenins are also parts of signal transduction pathways and play a role in phenotypical changes of cells, e.g., during switches from adherent to migratory cells. The function of catenins in such basic cellular processes also determines a role of catenins in embryogenesis, adult tissue homeostasis, and disease. In particular, β-catenin is known to be an important oncoprotein in human cancer development.


  • Top Cited Papers

    Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

    by Thomas Brabletz, Andreas Jung, Simone Reu, Marc Porzner, Falk Hlubek, Leoni A. Kunz-Schughart, Ruth Knuechel, Thomas Kirchner

    Invasion and dissemination of well-differentiated carcinomas are often associated with loss of epithelial differentiation and gain of mesenchyme-like capabilities of the tumor cells at the invasive front. However, when comparing central areas of primary colorectal carcinomas and corresponding metastases, we again found the same differentiated epithelial growth patterns. These characteristic phenotypic changes were associated with distinct expression patterns of β-catenin, the main oncogenic protein in colorectal carcinomas, and E-cadherin. Nuclear β-catenin was found in dedifferentiated mesenchyme-like tumor cells at the invasive front, but strikingly, as in central areas of the primary tumors, was localized to the membrane and cytoplasm in polarized epithelial tumor cells in the metastases. This expression pattern was accompanied by changes in E-cadherin expression and proliferative activity. On the basis of these data, we postulate that an important driving force for progression of well-differentiated colorectal carcinomas is the specific environment, initiating two transient phenotypic transition processes by modulating intracellular β-catenin distribution in tumor cells.


  • Tip60 Is a Cell-Type-Specific Transcriptional Regulator

    by Falk Hlubek, Christian Löhberg, Johannes Meiler, Andreas Jung, Thomas Kirchner, Thomas Brabletz

    Tip60 was originally identified as cellular HIV-Tat interacting protein and has been shown to augment Tat-dependent transcription. It has also been shown to interact with various cellular transcription factors and to belong to the nuclear histone acetyltransferase (HAT) family. To further elucidate the function of Tip60 and its HAT domain in transcription regulation, we compared Tip60 activity in HeLa and Jurkat T lymphoma cells. Here we show that Tip60 augments the HIV-1 Tat activity at the HIV-LTR promoter in HeLa but inhibits it in Jurkat cells. Moreover, we isolated two new variants of the Tip60 protein (Tip60Δ1, Tip60Δ2) from Jurkat cells. The Tip60Δ2 variant lacks the entire HAT domain but modulates HTV-1 Tat activity like full-length Tip60. In addition, Tip60 and the transcriptional repressor ZEB (zinc finger E box binding protein) interact specifically in the yeast two-hybrid system and additively inhibit the CD4 enhancer/promoter activity in Jurkat cells. Thus, Tip60 may function as corepressor of the ZEB protein. In summary, these data show that Tip60 functions as a cell-type-specific transcriptional regulator and that the HAT domain is not required for either transcriptional activation or inhibition. This indicates that Tip60 may function by recruiting additional cell-type-specific cofactors.